This circular advises of changes to the Drug Tariff with respect to remuneration arrangements for the dispensing pool month of September 2022.

The Scottish Government have released Circular PAC(P)(2022)29 which advises of an extension to the Serious Shortage Protocol (SSP) in place for Estraderm MX® 100 microgram patch, in place from 8 September, extended to 30 September 2022.

To advise of an extension to the Serious Shortage Protocol (SSP) in place for Estraderm MX® 25 microgram patch, in place from 8 September, extended to 30 September 2022.

This Circular advises NHS Boards and community pharmacy contractors that patient signatures are no longer required on the majority of prescription forms. It also provides an updated privacy notice for display in all community pharmacies.

This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of urinary tract infections (UTI) and impetigo under NHS Pharmacy First Scotland.

This Circular advises NHS Boards and community pharmacy contractors of an extension on 12 Serious Shortage Protocols (SSPs) issued recently for Hormone Replacement Therapies.

This Circular advises NHS Boards and community pharmacy contractors of the next Public Health Service (PHS) poster campaign topics which will start to be distributed to pharmacies from 12 July 2022.

This circular provides NHS Boards, prescribers and community pharmacy contractors with an update on progress and developments with regard to the GP IT Re-provisioning Programme and the support of the Electronic Transfer of Prescriptions (ETP) via the Acute Medication Service (AMS) for all non-medical prescribers working in GP Practices.

The Scottish Government has released ten new circulars outlining the introduction of temporary serious shortage protocols (SSPs) to help pharmacy teams manage demand for HRT products in short supply – these relate to Premique Low Dose tablets, Oestrogel, Ovestin, Lenzetto spray and Sandrena gel. In addition to the 3 SSPs released in late April, there are now a total of 13 live SSPs.

This circular advises of changes to the Drug Tariff with respect to remuneration arrangements for the dispensing pool month of March 2022. This temporary payment adjustment is required to regulate the delivery of the remuneration Global Sum for 2021/22.

To advise of a Serious Shortage Protocol (SSP) in place for Premique® Low Dose 0.3mg/1.5mg modified-release tablets, from 29 April to 29 July 2022.

To advise of a Serious Shortage Protocol (SSP) in place for Ovestin® 1mg cream, from 29 April to 29 July 2022.

To advise of a Serious Shortage Protocol (SSP) in place for Oestrogel® Pump-Pack 0.06% gel, from 29 April to 29 July 2022.

This circular sets out to community pharmacy contractors and NHS Boards the details of the community pharmacy funding arrangement 2022-23. This forms part of the 3-year settlement introduced in April 2020.

This Circular advises NHS Boards and community pharmacy contractors of the next Public Health Service (PHS) poster campaign topic which will start to be distributed to pharmacies from 11 April 2022.

Circular PCA(P)(2021)08 set out arrangements for a  pharmacy distribution service for members of the public to access lateral flow test kits. This circular notifies Health Boards and pharmacy contractors that arrangements for the service will end on Thursday 31 March 2022.

This Circular advises of a new ventilation enhancement allowance for community pharmacies in Scotland. Funding has been made available from the Scottish Government to be paid to community pharmacy contractors that meet the conditions of entitlement for the new allowance.

This Circular advises of a new ventilation enhancement allowance for community pharmacies in Scotland. Funding has been made available from the Scottish Government to be paid to community pharmacy contractors that meet the conditions of entitlement for the new allowance.

This circular sets out fees payable for participating community pharmacy contractors in the provision of antiviral treatments in COVID-19 positive non hospitalised patients.

Circular PCA (P)(2021)08 set out arrangements for a pharmacy distribution service for members of the public to access lateral flow test kits. Due to high demand for the service, stock levels of Orient Gene kits have been exhausted. Therefore, the UK Government is reintroducing Innova brand kits.